tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX

Compare Lineage Therap (LCTX) vs. Competitors

Compare
2,048 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Lineage Therap
$1.74
$400.77M
-5.66
164.04%
4 Buy
0 Hold
0 Sell
Strong Buy
Amarin
$14.78
$303.66M
-3.38
32.13%
Tvardi Therapeutics
$3.86
$36.21M
-0.36
-73.79%
3 Buy
3 Hold
0 Sell
Moderate Buy
DBV Technologies SA - American
$23.41
$930.89M
-4.09
416.78%
5 Buy
0 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$9.29
$473.86M
-2.13
36.64%
6 Buy
1 Hold
0 Sell
Strong Buy
Aura Biosciences Inc
$5.75
$365.14M
-2.78
-34.71%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LCTX
Lineage Therap
1.74
1.04
148.57%
AMRN
Amarin
14.60
3.17
27.73%
TVRD
Tvardi Therapeutics
3.86
-11.50
-74.87%
DBVT
DBV Technologies SA - American
23.41
19.01
432.05%
FDMT
4D Molecular Therapeutics
8.39
1.87
28.68%
AURA
Aura Biosciences Inc
5.36
-2.65
-33.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts